UnitedHealth Aktie
579,09USD | -31,84USD | -5,21% |
WKN: 869561 / ISIN: US91324P1021
Aktionärsstruktur
Inhaber | in % |
---|---|
Freefloat | 99,77 |
The Vanguard Group, Inc. | 9,11 |
Vanguard Group, Inc. (Subfiler) | 8,79 |
State Street Corp. | 4,95 |
Vanguard Total Stock Market ETF | 3,17 |
Capital Research & Management Co. (World Investors) | 2,85 |
BlackRock Fund Advisors | 2,79 |
Vanguard 500 Index Fund | 2,66 |
T Rowe Price Associates, Inc. (13F Subfiler) | 2,57 |
Wellington Management Co. LLP (Wellington Breakout) | 2,53 |
Fidelity Management & Research Co. LLC | 2,46 |
BlackRock Institutional Trust Co. NA | 2,19 |
Geode Capital Management LLC | 2,13 |
Capital Research & Management Co. (Global Investors) | 1,95 |
Capital Research & Management Co. (International Investors) | 1,60 |
*Die Summe der Anteile kann 100% überschreiten, da bestimmte Anteilseigner zum Freefloat dazu gerechnet wurden.
Personal
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Personal am Ende des Jahres | 325 000 | 330 000 | 350 000 | 400 000 | 440 000 |
Umsatz pro Mitarbeiter in Mio. EUR | 0,75 | 0,78 | 0,82 | 0,81 | 0,84 |
Bilanz (in Mio. USD) - Aktiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Umlaufvermögen | 42 634 | 53 718 | 61 758 | 69 069 | 78 437 |
Summe Anlagevermögen | 134 123 | 146 962 | 153 996 | 181 233 | 199 978 |
Summe Aktiva | 176 757 | 200 680 | 215 754 | 250 302 | 278 415 |
Bilanz (in Mio. USD) - Passiva
2019 | 2020 | 2021 | 2022 | 2023 | |
---|---|---|---|---|---|
Summe Fremdkapital | 114 595 | 130 141 | 139 275 | 163 955 | 179 496 |
Summe Eigenkapital | 62 162 | 70 539 | 76 479 | 86 347 | 98 919 |
Summe Passiva | 176 757 | 200 680 | 215 754 | 250 302 | 278 415 |
Adresse
9900 Bren Road East, 55343 Minnetonka | |
Telefon | +1 (800) 328-5979 |
Fax | +1 (800) 936-1819 |
Internet | http://www.unitedhealthgroup.com |
Management
Andrew Philip Witty
Chief Executive Officer & Director |
Brett Manderfeld
Senior VP-Capital Markets Communications Area |
Brian Thompson
Chief Executive Officer-UnitedHealthcare |
Charles D. Baker
Independent Director |
Chris Zaetta
Secretary, Chief Legal Officer & Executive VP |
D. Ellen Wilson
Executive Vice President |
Dame Vivian Hunt
Chief Innovation Officer |
Daniel J. Schumacher
Chief Strategy & Growth Officer |
Deedrea Grein
Vice President-Corporate Strategy |
Frances Jacobs
Senior Vice President-Investor Relations |
Frederick William McNabb
Independent Director |
John Franklin Rex
President & Chief Financial Officer |
John H. Noseworthy
Independent Director |
John Walthour
Vice President-Strategic Insights |
Joy Fitzgerald
SVP, Chief Diversity, Equity & Inclusion Officer |
Kristen L. Gil
Independent Director |
Kristi Hummel
Chief Talent Officer |
Kuai H. Leong
Deputy Secretary & Senior Deputy General Counsel |
Larry C. Renfro
Vice Chairman |
Margaret-Mary Wilson
Chief Medical Officer & Executive Vice President |
Michele J. Hooper
Lead Independent Director |
Patricia L. Lewis
Chief Sustainability Officer & Executive VP |
Paul R. Garcia
Independent Director |
Richard J. Mattera
Chief Development Officer & Senior Vice President |
Richard J. Migliori
Executive Vice President |
Rupert Mark Boden Bondy
Senior Counsel, EVP-Governance & Compliance |
Sandeep Dadlani
Chief Digital & Technology Officer & EVP |
Stephanie L. Fehr
Chief Human Capital Officer & EVP-UnitedHealthcare |
Stephen J. Hemsley
Chairman |
Terry M. Clark
Chief Customer & Marketing Officer & Executive VP |
Thomas Edward Roos
Chief Accounting Officer & Executive VP |
Timothy Patrick Flynn
Independent Director |
Todd Walthall
Executive Vice President-Enterprise Growth |
Valerie C. Montgomery Rice
Independent Director |
Zack Sopcak
Senior Vice President-Investor Relations |